Cardiovascular gene therapy: Current concepts

Therapeutic Drug Monitoring

Volumn 18, Issue 4, 1996, Pages 410-422

  Fox, Jonathan C ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Stellar Chance Laboratories   (United States)

Author keywords

Cardiovascular therapeutics; Gene therapy; Toxicity; Vectors

Indexed keywords

ADENOVIRUS; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; DNA RECOMBINATION; EXPRESSION VECTOR; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC RECOMBINATION; HUMAN; HYPERLIPIDEMIA; NONHUMAN; PRIORITY JOURNAL; RETROVIRUS;

ADENOVIRIDAE; CARDIOVASCULAR DISEASES; DNA, VIRAL; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; RETROVIRIDAE; TRANSFECTION;

EID: 0029789790     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199608000-00018     Document Type: Conference Paper

References (110)

1. Felgner PL, Gadek TR, Holm M, et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 1987;84:7413.
2. Stewart MJ, Plautz GE, Del BL, et al. Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice. Hum Gene Ther 1992;3:267-75.
3. Nabel EG, Gordon D, Yang ZY, et al. Gene transfer in vivo with DNA-liposome complexes: lack of autoimmunity and gonadal localization. Hum Gene Ther 1992;3:649-56.
4. San H, Yang ZY, Pompili VJ, et al. Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy. Hum Gene Ther 1993;4:781-8.
5. Miller AD, Miller DG, Garcia JV, Lynch CM. Use of retroviral vectors for gene transfer and expression. Methods Enzymol 1993;217:581-99.
6. Boris LK, Temin HM. Recent advances in retrovirus vector technology. Curr Opin Genet Dev 1993;3:102-9.
7. Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990;10:4239-42.
8. Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci USA 1993;90:8033-7.
9. Yee JK, Miyanohara A, Laporte P, Bouic K, Burns JC, Friedmann T. A general-method for the generation of high-titer, pantropic retroviral vectors - highly efficient infection of primary hepatocytes. Proc Natl Acad Sci USA 1994;91:9564-8.
10. Burns JC, Matsubara T, Lozinski G,et al. Pantropic retroviral vector-mediated gene transfer, integration, and expression in cultured newt limb cells. Dev Biol 1994;165:285-9.
11. Lin S, Gaiano N, Culp P, et al. Integration and germ-line transmission of a pseudotyped retroviral vector in zebrafish. Science 1994;265:666-9.
12. Cornetta K, Morgan RA, Anderson WF. Safety issues related to retroviral-mediated gene transfer in humans. Hum Gene Ther 1991;2:5-14.
13. Boris LK, Temin HM. The retroviral vector. Replication cycle and safety considerations for retrovirus-mediated gene therapy. Ann NY Acad Sci 1994;716:59-70.
14. Graham FL, Prevec L. Adenovirus-based expression vectors and recombinant vaccines. Biotechnology 1992;20: 363-90.
15. Haj AY, Graham FL. Development of a helper-independent human adenovirus vector and its use in the transfer of the herpes simplex virus thymidine kinase gene. J Virol 1986;57:267-74.
16. Engelhardt JF, Litzky L, Wilson JM. Prolonged transgene expression in cotton rat lung with recombinant adenoviruses defective in E2a. Hum Gene Ther 1994;5:1217-29.
17. Kass-Eisler A, Falck-Pedersen E, Elfenbein DH, Alvira M, Buttrick PM, Leinwand LA. The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther 1994;1: 395-402.
18. Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, Wilson JM. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994;91:4407-11.
19. Engelhardt JF, Ye X, Doranz B, Wilson JM. Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA 1994;91:6196-200.
20. Nahreini P, Larsen SH, Srivastava A. Cloning and integration of DNA fragments in human cells via the inverted terminal repeats of the adeno-associated virus 2 genome. Gene 1992;119:265-72.
21. Samulski RJ. Adeno-associaled virus: integration at a specific chromosomal locus. Curr Opin Genet Dev 1993;3: 74-80.
22. Russell DW, Miller AD, Alexander IE. Adeno-associated virus vectors preferentially transduce cells in S phase. Proc Natl Acad Sci USA 1994;91:8915-9.
23. Nahreini P, Woody MJ, Zhou SZ, Srivastava A. Versatile adeno-associated virus 2-based vectors for constructing recombinant virions. Gene 1993;124:257-62.
24. Podsakoff G, Wong KJ, Chatterjee S. Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J Virol 1994;68:5656-66.
25. Flotte TR, Afione SA, Conrad C, et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sci USA 1993;90:10613-7.
26. Walsh CE, Nienhuis AW, Samulski RJ, et al. Phenotypic correction of fanconi-anemia in human hematopoietic-cells with a recombinant adenoassociated virus vector. J Clin Invest 1994;94:1440-8.
27. Geller AI, Keyomarsi K, Bryan J, Pardee AB. An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology. Proc Natl Acad Sci USA 1990;87:8950-4.
28. Pincus S, Mason PW, Konishi E, et al. Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis. Virology 1992;187:290-7.
29. Stein CA. Anti-sense oligodeoxynucleotides - promises and pitfalls. Leukemia 1992;6:967-74.
30. Bredenbeek PJ, Frolov I, Rice CM, Schlesinger S. Sindbis virus expression vectors: packaging of RNA replicons by using defective helper RNAs. J Virol 1993;67:6439-46.
31. Michael SI, Curiel DT. Strategies to achieve targeted gene delivery via the receptor-mediated endocytosis pathway. Gene Ther 1994;1:223-32.
32. Cotten M, Wagner E, Zatloukal K, Phillips S, Curiel DT, Birnstiel ML. High-efficiency receptor-mediated delivery of small and large (48 kilobase) gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles. Proc Natl Acad Sci USA 1992;89:6094-8.
33. Cotten M, Wagner E, Zatloukal K, Birnstiel ML. Chicken adenovirus (CELO virus) particles augment receptor-mediated DNA delivery to mammalian cells and yield exceptional levels of stable transformants. J Virol 1993;67:3777-85.
34. Morishita R, Gibbons GH, Kaneda Y, Ogihara T, Dzau VJ. Novel and effective gene transfer technique for study of vascular renin angiotensin system. J Clin Invest 1993;91: 2580-5.
35. Wagner E, Zatloukal K, Cotten M, et al. Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc Natl Acad Sci USA 1992;89: 6099-103.
36. Fisher KJ, Wilson JM. Biochemical and functional analysis of an adenovirus-based ligand complex for gene transfer. Biochem J 1994.
37. Plank C, Zatloukal K, Gotten M, Mechtler K, Wagner E. Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand. Bioconjugate Chem 1992;3:533-9.
38. Wagner E, Plank C, Zatloukal K, Cotten M, Birnstiel ML. Influenza virus hemagglutinin HA-2 N-terminal fusogenic peptides augment gene transfer by transferrin-polylysine-DNA complexes: toward a synthetic virus-like gene-transfer vehicle. Proc Natl Acad Sci USA 1992;89:7934-8.
39. Stein CA, Cheng YC. Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science 1993; 261:1004-12.
40. Hanvey JC, Peffer NJ, Bisi JE, et al. Antisense and antigene properties of peptide nucleic acids. Science 1992;258: 1481-5.
41. Bock LC, Griffin LC, Latham JA, Vermaas EH, Toole JJ. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 1992;355:564-6.
42. Conrad R, Keranen LM, Ellington AD, Newton AC. Isozyme-specific inhibition of protein kinase C by RNA aptamers. J Biol Chem 1994;269:32051-4.
43. Stein CA, Cleary AM, Yakubov L, Lederman S. Phosphorothioate oligodeoxynucleotides bind to the third variable loop domain (v3) of human immunodeficiency virus type 1 gp120. Antisense Res Dev 1993;3:19-31.
44. Melton DA. Injected anti-sense RNAs specifically block messenger RNA translation in vivo. Proc Natl Acad Sci USA 1985;82:144-8.
45. Green PJ, Pines O, Inouye M. The role of antisense RNA in gene regulation. Annu Rev Biochem 1986;55:569-97.
46. Takayama KM, Inouye M. Antisense RNA. Crit Rev Biochem Mol Biol 1990;25:155-84.
47. Fox JC, Hsu AY, Swain JL. Myogenic differentiation triggered by antisense acidic fibroblast growth factor RNA. Mol Cell Biol 1994;14:4244-50.
48. Beauparlant P, Kwan I, Bitar R, et al. Disruption of I kappa B alpha regulation by antisense RNA expression leads to malignant transformation. Oncogene 1994;9:3189-97.
49. Borycki AG, Foucrier J, Saffar L, Leibovitch SA. Repression of the CSF-1 receptor (c-fms proto-oncogene product) by antisense transfection induces G1-growth arrest in L6 alpha 1 rat myoblasts. Oncogene 1995;10:1799-811.
50. Long L, Rubin R, Baserga R, Brodt P. Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor. Cancer Res 1995;55:1006-9.
51. Nakanishi M, Adami GR, Robetorye RS, et al. Exit from GO and entry into the cell cycle of cells expressing p21Sdi1 antisense RNA. Proc Natl Acad Sci USA 1995;92:4352-6.
52. Altman S. RNA enzyme-directed gene therapy. Proc Natl Acad Sci USA 1993;90:10898-900.
53. Sullivan SM. Development of ribozymes for gene therapy. J Invest Dermatol 1994;103(suppl 5):85S-9S.
54. Krieg AM, Tonkinson J, Matson S, et al. Modification of antisense phosphodiester oligodeoxynucleotides by a 5′ cholesteryl moiety increases cellular association and improves efficacy. Proc Natl Acad Sci USA 1993;90:1048-52.
55. Wilson JM, Birinyi LK, Salomon RN, Libby P, Callow AD, Mulligan RC. Implantation of vascular grafts lined with genetically modified endothelial cells. Science 1989;244: 1344-6.
56. Nabel EG, Plautz G, Boyce FM, Stanley JC, Nabel GJ. Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science 1989;244:1342-4.
57. Plautz G, Nabel EG, Nabel GJ. Introduction of vascular smooth muscle cells expressing recombinant genes in vivo. Circulation 1991;83:578-83.
58. Clowes MM, Lynch CM, Miller AD, Miller DG, Osborne WR, Clowes AW. Long-term biological response of injured rat carotid artery seeded with smooth muscle cells expressing retrovirally introduced human genes. J Clin Invest 1994;93:644-51.
59. Lim CS, Chapman GD, Gammon RS, et al. Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog. Circulation 1991;83:2007-11.
60. Chapman GD, Lim CS, Gammon RS, et al. Gene transfer into coronary arteries of intact animals with a percutaneous balloon catheter. Circ Res 1992;71:27-33.
61. Leclerc G, Gal D, Takeshita S, Nikol S, Weir L, Isner JM. Percutaneous arterial gene transfer in a rabbit model. Efficiency in normal and balloon-dilated atherosclerotic arteries. J Clin Invest 1992;90:936-44.
62. Takeshita S, Zheng LP, Brogi E, et al. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 1994;93:662-70.
63. Takeshita S, Weir L, Zheng LP, et al. Therapeutic angiogenesis following arterial gene transfer of vascular endothelail growth factor in a rabbit model of hindlimb ischemia. Proc Natl Acad Sci USA (in press).
64. Isner JM, Walsh K, Symes J, et al. Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circulation 1995;91:2687-92.
65. Nabel EG, Plautz G, Nabel GJ. Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science 1990;249:1285-8.
66. Flugelman MY, Jaklitsch MT, Newman KD, Casscells W, Bratthauer GL, Dichek DA. Low level in vivo gene transfer into the arterial wall through a perforated balloon catheter. Circulation 1992;85:1110-7.
67. Lee SW, Trapnell BC, Rade JJ, Virmani R, Dichek DA. In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries. Circ Res 1993;73:797-807.
68. Guzman RJ, Lemarchand P, Crystal RG, Epstein SE, Finkel T. Efficient and selective adenovirus-mediated gene transfer into vascular neointima. Circulation 1993;88:2838-48.
69. Lemarchand P, Jones M, Yamada I, Crystal RG. In vivo gene-transfer and expression in normal uninjured blood-vessels using replication-deficient recombinant adenovirus vectors. Circ Res 1993;72:1132-8.
70. French BA, Mazur W, Ali NM, et al. Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis. Circulation 1994; 90:2402-13.
71. Steg PG, Feldman LJ, Scoazec JY, et al. Arterial gene-transfer to rabbit endothelial and smooth-muscle cells using percutaneous delivery of an adenoviral vector. Circulation 1994;90:1648-56.
72. Casscells W. Migration of smooth muscle and endothelial cells. Critical events in restenosis. Circulation 1992;86: 723-9.
73. Libby P, Schwartz D, Brogi E, Tanaka H, Clinton SK. A cascade model for restenosis. A special case of atherosclerosis progression. Circulation 1992;86:III47-52.
74. Casscells W, Engler D, Willerson JT. Mechanisms of restenosis. J Texas Heart Inst 1994;21:68-77.
75. Ohno T, Gordon D, San H, et al. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 1994;265:781-4.
76. Guzman RJ, Hirschowitz EA, Brody SL, Crystal RG, Epstein SE, Finkel T. In vivo suppression of injury-induced vascular smooth muscle cell accumulation using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene. Proc Natl Acad Sci USA 1994;91:10732-6.
77. Chang MW, Barr E, Seltzer J, et al. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 1995;267:518-22.
78. Von der Leyen HE, Gibbons GH, Morishita R, et al. Gene-therapy inhibiting neointimal vascular lesion - in vivo transfer of endothelial-cell nitric-oxide synthase gene. Proc Natl Acad Sci USA 1995;92:1137-41.
79. Simons M, Edelman ER, DeKeyser J-L, Langer R, Rosenberg RD. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature 1992;359:67-70.
80. Bennett MR, Anglin S, McEwan JR, Jagoe R, Newby AC, Evan GI. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. J Clin Invest 1994;93:820-8.
81. Shi Y, Fard A, Galeo A, et al. Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury. Circulation 1994;90:944-51.
82. Simons M, Edelman ER, Rosenberg RD. Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimai hyperplasia in a rat carotid artery injury model. J Clin Invest 1994;93:2351-6.
83. Simons M, Rosenberg RD. Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro. Circ Res 1992;70:835-43.
84. Morishita R, Gibbons GH, Ellison KE, et al. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci USA 1993;90:8474-8.
85. Morishita R, Gibbons GH, Ellison KE, et al. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J Clin Invest 1994;93:1458-64.
86. Field LJ. Atrial natriuretic factor-SV40 T antigen transgenes produce tumors and cardiac arrhythmias in mice. Science 1988;239:1029-33.
87. Jackson T, Allard MF, Sreenan CM, Doss LK, Bishop SP, Swain JL. The c-myc proto-oncogene regulates cardiac development in transgenic mice. Mol Cell Biol 1990;10: 3709-16.
88. GruverCL, DeMayo F, Goldstein MA, Means AR. Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice. Endocrinology 1993;133:376-88.
89. Milano CA, Allen LF, Rockman HA, et al. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. Science 1994;264:582-6.
90. Milano CA, Dolber PC, Rockman HA, et al. Myocardial expression of a constitutively active alpha(1b)-adrenergic receptor in transgenic mice induces cardiac-hypertrophy. Proc Natl Acad Sci USA 1994;91:10109-13.
91. Lin H, Parmacek MS, Morle G, Boiling S, Leiden JM. Expression of recombinant genes in myocardium in vivo after direct injection of DNA. Circulation 1990;82:2217-21.
92. Acsadi G, Jiao SS, Jani A, et al. Direct gene transfer and expression into rat heart in vivo. New Biologist 1991;3: 71-81.
93. Buttrick PM, Kass A, Kitsis RN, Kaplan ML, Leinwand LA. Behavior of genes directly injected into the rat heart in vivo. Circ Res 1992;70:193-8.
94. Buttrick PM, Kaplan ML, Kitsis RN, Leinwand LA. Distinct behavior of cardiac myosin heavy chain gene constructs in vivo. Discordance with in vitro results. Circ Res 1993;72:1211-7.
95. von Harsdorf R, Schott RJ, Shen YT, Vatner SF, Mahdavi V, Nadal GB. Gene injection into canine myocardium as a useful model for studying gene expression in the heart of large mammals. Circulation Res 1993;72:688-95.
96. Kitsis RN, Buttrick PM, McNally EM, Kaplan ML. Leinwand LA. Hormonal modulation of a gene injected into rat heart in vivo. Proc Natl Acad Sci USA 1991;88:4138-42.
97. Stratford-Perricaudet LD, Makeh I, Perricaudet M, Briand P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest 1992;90:626-30.
98. Guzman RJ, Lemarchand P, Crystal RG, Epstein SE, Finkel T. Efficient gene transfer into myocardium by direct injection of adenovirus vectors. Circ Res 1993;73:1202-7.
99. French BA, Mazur W, Geske RS, Bolli R. Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. Circulation 1994;90:2414-24.
100. Barr E, Carroll J, Kalynych AM, et al. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther 1994;1:51-8.
101. Wilson JM, Grossman M. Therapeutic strategies for familial hypercholesterolemia based on somatic gene transfer. Am J Cardiol 1993;72.
102. Strauss M. Liver-directed gene therapy: prospects and problems. Gene Ther 1994;1:156-64.
103. Ponder KP, Gupta S, Leland F, et al. Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc Natl Acad Sci USA 1991;88:1217-21.
104. Bilheimer DW, Goldstein JL, Grundy SM, Starzl TE, Brown MS. Liver transplantation to provide low-density-lipoprotein receptors and lower plasma cholesterol in a child with homozygous familial hypercholesterolemia. N Engl J Med 1984;311:1658-64.
105. Wilson JM, Chowdhury NR, Grossman M, et al. Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes. Proc Natl Acad Sci USA 1990;87: 8437-41.
106. Grossman M, Raper SE, Kozarsky K, et al. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nature Gen 1994;6:335-41.
107. Herz J, Gerard RD. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci USA 1993;90:2812-6.
108. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 1993;92:883-93.
109. Kozarsky KF, McKinley DR, Austin LL, Raper SE, Stratford PL, Wilson JM. In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J Biol Chem 1994 ;269:13695-702.
110. Kozarsky K, Grossman M, Wilson JM. Adenovirus-mediated correction of the genetic defect in hepatocytes from patients with familial hypercholesterolemia. Som Cell Mol Genet 1993;19:449-58.